spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 30 October 2007
doi: 10.1242/jcs.010009

Journal of Cell Science 120, 4050-4059 (2007)
Published by The Company of Biologists 2007
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow All Versions of this Article:
jcs.010009v1
120/22/4050    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ödemis, V.
Right arrow Articles by Engele, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ödemis, V.
Right arrow Articles by Engele, J.

Research Article

The chemokine SDF1 controls multiple steps of myogenesis through atypical PKC{zeta}

Veysel Ödemis1,*, Karina Boosmann1,*, Maja Theresa Dieterlen2 and Jürgen Engele1,{ddagger}

1 Institute of Anatomy, Medical Faculty, University of Leipzig, Liebigstr. 13, 04103 Leipzig, Germany
2 Department of Neurology, University of Leipzig, Liebigstr. 22a, 04103 Leipzig, Germany

{ddagger} Author for correspondence (e-mail: engj{at}medizin.uni-leipzig.de)

Accepted 14 September 2007

Mice deficient in the SDF1-chemokine-receptor CXCR4, exhibit severe defects of secondary limb myogenesis. To further elucidate the role of SDF1 in muscle development, we have now analyzed putative effects of this chemokine on proliferation, migration and myogenic differentiation of mouse C2C12 myogenic progenitor/myoblast cells. In addition, we have characterized the signaling pathways employed by SDF1-CXCR4 to control myogenesis. We found that SDF1 stimulates proliferation and induces migration of C2C12 cells with a potency similar to that of FGF2 and HGF, which both represent prototypical extracellular regulators of myogenesis. In addition, SDF1 inhibits myogenic differentiation in both C2C12 cells and primary myoblasts, as assessed by MyoD, myosin heavy chain and/or myogenin expression. Regarding signaling pathways, C2C12 cells responded to SDF1 with activation (phosphorylation) of Erk and PKC{zeta}, whereas even after prolonged SDF1 treatment for up to 120 minutes, levels of activated Akt, p38 and PKC{alpha} or PKCβ remained unaffected. Preventing activation of the classic MAP kinase cascade with the Erk inhibitor UO126 abolished SDF1-induced proliferation and migration of C2C12 cells but not the inhibitory action of SDF1 on myogenic differentiation. Moreover, the effects of SDF1 on proliferation, migration and differentiation of C2C12 cells were all abrogated in the presence of myristoylated PKC{zeta} peptide pseudosubstrate and/or upon cellular depletion of PKC{zeta} by RNA interference. In conclusion, our findings unravel a previously unknown role of CXCR4-PKC{zeta} signaling in myogenesis. The potent inhibitory effects of SDF1 on myogenic differentiation point to a major function of CXCR4-PKC{zeta} signaling in the control of secondary muscle growth.

Key words: CXCR4, Myogenin, MyoD, Myosin heavy chain, Myoblasts






© The Company of Biologists Ltd 2007